Literature DB >> 3381299

Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.

D Ludwin1, K J Bennett, E M Grace, W W Buchanan, W Bensen, C Bombardier, P X Tugwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3381299

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Monitoring cyclosporin treatment.

Authors:  C Speed
Journal:  BMJ       Date:  1993-02-06

3.  The clinical and immunological effects of cyclosporin A on patients with rheumatoid arthritis.

Authors:  D M Chang; S F Chiao
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

4.  Comparison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis--results of a double-blind multicentre study.

Authors:  K Krüger; M Schattenkirchner
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

Review 5.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.